Sanofi posts results across four trials; RSV toddler study OPAL ended early by sponsor decisionAug 6Weekly roundup, 4 itemsrilzabrutinibSanofi
Sanofi posts rilzabrutinib atopic dermatitis results; opens Phase 3 meningococcal vaccine trial in CJul 17Weekly roundup, 2 itemsrilzabrutinibSanofi
Sign inSign in